Skip to content

Effect of bupivacaine liposomal brachial plexus nerve block on quality of recovery after rotator cuff repair

Effect of bupivacaine liposomal brachial plexus nerve block on quality of recovery after rotator cuff repair: a prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099378
Enrollment
Unknown
Registered
2025-03-21
Start date
2024-09-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff repair

Interventions

Bupivacaine group:10 ml of 0.5% bupivacaine and 10 ml of normal saline
bupivacaine and bupivacaine liposomal group:Addition of bupivacaine liposomes

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Inclusion of persons aged 18 years and over, regardless of sex; 2.American Society of Anesthesiologists (ASA) Classification I-III; 3.Repair of rotator cuff injury under general anesthesia;

Exclusion criteria

Exclusion criteria: 1. Abnormal coagulation function, allergy to anesthetic drugs, and neurological loss; 2.Skin infection or breakdown of the puncture portion, severe diabetes (with associated complications such as peripheral neuropathy); 3. Hearing impairment or speech impairment; 4. Patients who cannot understand the ASA score and refuse to accept cooperation; 5. IBPB doesn't work well; 6. Occurrence of serious adverse events during anesthesia; 7. Patients should be treated with analgesic pumps after surgery.

Design outcomes

Primary

MeasureTime frame
Postoperative 48h Quality of Recovery Score QoR;

Secondary

MeasureTime frame
Preoperative, postoperative 6, 12, 24, 48, 72h muscle strength grading;Quality of recovery scores at 24h and 72h postoperatively;NRS scores at rest and during exercise in preoperative, 6, 12, 24, 48, and 72h postoperative patient;Perioperative use of sufentanil and remifentanil;Incidence of various adverse effects (postoperative nausea and vomiting, hypertension, hypotension, bradycardia, etc.) and length of hospitalization in perioperative patients;

Countries

China

Contacts

Public ContactJi Fuhai

The First Affiliated Hospital of Soochow University

szliusl@126.com+86 135 8482 0752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026